Vascular Diseases  >>  Decadron (dexamethasone)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

14 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Decadron (dexamethasone) / Merck (MSD)
NCT01969565: Study of Carfilzomib in Combination w/Dexamethasone in Patients w/Newly Diagnosed Multiple Myeloma

Terminated
1b
1
US
Carfilzomib, Kyprolis, Dexamethasone, Decadron
Emory University, Onyx Therapeutics, Inc.
Multiple Myeloma
10/14
10/14
NCT00091624: A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)

Completed
1
77
US
CC-5013
Celgene Corporation
Multiple Myeloma
09/07
09/07
NCT00258245: Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Completed
1
5
US
ascorbic acid, All Day C CR, Ascot, C Complex, C-500, C-500-Gr, C-Time, Cecon, Cemill 1000, Cemill 500, Centrum Singles-Vitamin C, Cevi-Bid, N Ice with Vitamin C, Special C, Sunkist Vitamin C, Vicks Vitamin C Drops, Vitamin C TR, arsenic trioxide, Trisenox®, bortezomib, Velcade®, dexamethasone, Dexasone, Decadron, Diodex, Hexadrol, Maxidex, Dexamethasone Sodium Phosphate, Dexamethasone Acetate, thalidomide, Thalomid, Aspirin, Acuprin 81, Anacin Aspirin Regimen, Ascriptin, Ascriptin Enteric, Aspergum, Aspidrox, Aspir-Low, Aspir-Mox, Aspir-trin, Aspirtab, Bayer Aspirin, Bufferin, Buffex, Easprin, Ecotrin, Ecpirin, Empirin, Entaprin, Entercote, Fasprin, Genacote, Gennin-FC, Genprin, Halfprin, Magnaprin, Med Aspirin, Migralex, Miniprin, Minitabs, Norwich Aspirin, Ridiprin, Sloprin, St. Joseph Aspirin, Uni-Buff, Uni-Tren, Valomag, Zero-Order Release, Zorprin
Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI)
Multiple Myeloma and Plasma Cell Neoplasm
04/08
04/08
NCT00525447: Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

Completed
1
36
US
SGN-40, dacetuzumab, lenalidomide, Revlimid, dexamethasone, Decadron
Seagen Inc., Genentech, Inc.
Multiple Myeloma
01/10
02/10
NCT00871910: Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)

Checkmark P1 data
Jun 2011 - Jun 2011: P1 data
Completed
1
81
NA
SCH 727965, Aprepitant, Emend, Ondansetron, Zofran, Dexamethasone, Decadron
Merck Sharp & Dohme LLC
Solid Tumors, Lymphoma, Non-Hodgkin, Multiple Myeloma
02/10
02/10
NCT00693433: Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma

Completed
1
15
US
dexamethasone, Aeroseb-Dex, Decaderm, Decadron, DM, DXM, temsirolimus, CCI-779, cell cycle inhibitor 779, Torisel, laboratory biomarker analysis
National Cancer Institute (NCI)
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
08/10
 
NCT01680796: Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma

Withdrawn
1
0
US
Dovitinib, TKI258, Bortezomib, Velcade, Dexamethasone, Decadron
University of Florida, Novartis Pharmaceuticals
Multiple Myeloma
02/13
02/13
NCT01393964: Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

Completed
1
35
US
Lenalidomide, Revlimid®, Dexamethasone, Decadron®, Dexamethasone Intensol®, Dexpak® Taperpak®, Elotuzumab (BMS-901608; HuLuc63)
Bristol-Myers Squibb, AbbVie
Multiple Myeloma
03/14
07/16
NCT01078974: Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia

Terminated
1
7
US
pomalidomide, CC-4047, Pomalyst, dexamethasone, Decadron, rituximab, Rituxan
Steven P. Treon, MD, PhD, Celgene Corporation
Waldenstrom's Macroglobulinemia
09/15
03/16
NCT01485835: A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma

Completed
1
8
US
Ganetespib, STA-9090, Bortezomib, Velcade, Dexamethasone, Decadron
Emory University, Multiple Myeloma Research Consortium, Synta Pharmaceuticals Corp.
Multiple Myeloma
09/15
09/15
NCT01549431: Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma

Completed
1
32
US
Panobinostat, LBH589, Carfilzomib, Kyprolis, Dexamethasone, Decadron
Emory University, Multiple Myeloma Research Consortium, Novartis, Onyx Therapeutics, Inc., Amgen, University of California, San Francisco, University of Chicago
Multiple Myeloma
02/16
04/17
NCT01204164: Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies

Completed
1
120
US
TG02 citrate, No other names., Carfilzomib, Kyprolis, Dexamethasone, Ozurdex, Maxidex, Decadron, Baycadron
Tragara Pharmaceuticals, Inc.
AML, ALL, Blast Crisis, MDS, Multiple Myeloma
03/16
04/16
NCT01689987: Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

Completed
1
18
US
Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Fluorodelta, Fortecortin, Gammacorten, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, Visumetazone, Hydroxychloroquine, Laboratory Biomarker Analysis, Pharmacological Study, Sirolimus, AY 22989, RAPA, Rapamune, RAPAMYCIN, SILA 9268A, WY-090217
OHSU Knight Cancer Institute, National Cancer Institute (NCI)
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
04/16
 
NCT01440582: Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients

Completed
1
77
US
Panobinostat, LBH589B, Bortezomib, Velcade, LDP-341, MLN341, PS-341, Lenalidomide, CC-5013, Revlimid, Dexamethasone, Decadron, Symptom Questionnaire, Survey
M.D. Anderson Cancer Center, Novartis
Myeloma
02/19
02/19

Download Options